熱門資訊> 正文
Tenax Therapeutics任命Thomas Staab为首席财务官
2026-04-22 19:38
- Tenax Therapeutics (TENX) has appointed Thomas Staab as chief financial officer, effective May 11, 2026, replacing Thomas McGauley.
- Staab brings over 25 years of leadership experience across management and corporate finance roles in the healthcare industry, the company said. He most recently served as CFO and Secretary of LENSAR until May 2026 and Senior Vice President, CFO, and Treasurer at BioCryst Pharmaceuticals from July 2011 to February 2020.
- TENX +0.88% premarket to $13.8.
- Source: Press Release
More on Tenax Therapeutics
- Tenax Therapeutics: A Binary Bet With Heavy Downside Likely
- Tenax Therapeutics: Some Future Potential
- Tenax wins bullish view at Cantor ahead of pivotal readout
- Seeking Alpha’s Quant Rating on Tenax Therapeutics
- Historical earnings data for Tenax Therapeutics
推薦文章
【一期一會】時代的變遷：告別石油美元？——特朗普"玩脱"與中東亂局下的資產重估
一周IPO | 2026年港股IPO「漲幅王」誕生！曦智科技首日大漲383.62%；天星醫療孖展認購超6395倍，預計下周上市
華盛早報 | 特朗普封鎖威脅升級！油價飆漲7%升破110美元；明星科技股績后分化！高通飆升超13%，谷歌漲近7%，Meta跌超6%
新股申購 | 全球機器人視覺龍頭樂動機器人今起招股，一手入場費6060.51港元
美股機會日報 | 鮑威爾絕唱！美聯儲利率決議今夜來襲；希捷績后勁升逾18%，盤后谷歌、微軟四巨頭齊放榜！
財報前瞻 | CPU嚴重缺貨！AMD一季度淨利料同比暴增197%，如何提前部署期權策略？
上市狂飆50%！除了這隻被亞馬遜看好的「核電新貴」，產業鏈還有哪些機會值得關注？
休市提醒：港股因勞動節5月1日休市一天，美股照常交易
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
